|Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters|
TE Sweeney, TD Azad, M Donato, WA Haynes, TM Perumal, R Henao, ...
Critical care medicine 46 (6), 915, 2018
|A community approach to mortality prediction in sepsis via gene expression analysis|
TE Sweeney, TM Perumal, R Henao, M Nichols, JA Howrylak, AM Choi, ...
Nature communications 9 (1), 1-10, 2018
|A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia|
GP Parnell, AS McLean, DR Booth, NJ Armstrong, M Nalos, SJ Huang, ...
Critical Care 16 (4), 1-12, 2012
|Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions|
GP Parnell, BM Tang, M Nalos, NJ Armstrong, SJ Huang, DR Booth, ...
Shock 40 (3), 166-174, 2013
|Immune effects of interferon gamma in persistent staphylococcal sepsis|
M Nalos, B Santner-Nanan, G Parnell, B Tang, AS McLean, R Nanan
American journal of respiratory and critical care medicine 185 (1), 110-112, 2012
|Aberrant cell cycle and apoptotic changes characterise severe influenza A infection–a meta-analysis of genomic signatures in circulating leukocytes|
G Parnell, A McLean, D Booth, S Huang, M Nalos, B Tang
Plos one 6 (3), e17186, 2011
|The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to MS pathogenesis and identify novel therapeutic opportunities|
GP Parnell, DR Booth
Frontiers in immunology 8, 425, 2017
|Fetal–maternal alignment of regulatory T cells correlates with IL-10 and Bcl-2 upregulation in pregnancy|
B Santner-Nanan, K Straubinger, P Hsu, G Parnell, B Tang, B Xu, ...
The Journal of Immunology 191 (1), 145-153, 2013
|Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection|
BM Tang, M Shojaei, S Teoh, A Meyers, J Ho, TB Ball, Y Keynan, ...
Nature communications 10 (1), 1-13, 2019
|The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease|
GP Parnell, PN Gatt, M Krupa, D Nickles, FC McKay, SD Schibeci, ...
Clinical immunology 151 (1), 16-24, 2014
|The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells|
F Shahijanian, GP Parnell, FC McKay, PN Gatt, M Shojoei, KS O'Connor, ...
Human molecular genetics 23 (6), 1425-1434, 2014
|Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases|
DR Booth, N Ding, GP Parnell, F Shahijanian, S Coulter, SD Schibeci, ...
Genes & Immunity 17 (4), 213-219, 2016
|A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection|
BM Tang, M Shojaei, GP Parnell, S Huang, M Nalos, S Teoh, K O'Connor, ...
European Respiratory Journal 49 (6), 2017
|The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function|
J Field, F Shahijanian, S Schibeci, ...
PloS one 10 (6), e0127080, 2015
|The antiviral role of zinc and metallothioneins in hepatitis C infection|
SA Read, G Parnell, D Booth, MW Douglas, J George, G Ahlenstiel
Journal of viral hepatitis 25 (5), 491-501, 2018
|Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent|
KS O'Connor, G Parnell, E Patrick, G Ahlenstiel, V Suppiah, ...
Genes & Immunity 15 (2), 88-94, 2014
|The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis|
NL Fewings, PN Gatt, FC McKay, GP Parnell, SD Schibeci, J Edwards, ...
Journal of autoimmunity 78, 57-69, 2017
|Transcriptional reprogramming of metabolic pathways in critically ill patients|
M Nalos, G Parnell, R Robergs, D Booth, AS McLean, BM Tang
Intensive care medicine experimental 4 (1), 1-15, 2016
|The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies|
FC McKay, PN Gatt, N Fewings, GP Parnell, SD Schibeci, MAI Basuki, ...
Clinical Immunology 163, 96-107, 2016
|Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season|
GP Parnell, PN Gatt, FC McKay, S Schibeci, M Krupa, JE Powell, ...
Multiple Sclerosis Journal 20 (6), 675-685, 2014